Literature DB >> 18509652

Leukocytapheresis for the treatment of refractory Henoch-Schönlein purpura resistant to both prednisolone and intravenous immunoglobulin therapy.

Eishin Oki, Koji Tsugawa, Koichi Suzuki, Etsuro Ito, Hiroshi Tanaka.   

Abstract

Henoch-Schönlein purpura (HSP) is a childhood disorder, which is the vasculitis of systemic small vessels of unknown etiology. We encountered the dramatic efficacy of leukocytapheresis in a Japanese girl with refractory HSP resistant to combined prednisolone plus intravenous immunoglobulin therapy administration.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18509652     DOI： 10.1007/s00296-008-0610-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


  6 in total

1.  Leukocytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowel disease.

Authors:  K Sawada; K Ohnishi; S Fukui; K Yamada; M Yamamura; K Amano; K Amano; M Wada; N Tanida; M Satomi
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527

2.  Activity of blood coagulation factor XIII as a prognostic indicator in patients with Henoch-Schönlein purpura. Efficacy of factor XIII substitution.

Authors:  H Kamitsuji; K Tani; M Yasui; A Taniguchi; K Taira; S Tsukada; Y Iida; H Kanki; H Fukui
Journal:  Eur J Pediatr       Date:  1987-09       Impact factor: 3.183

3.  Leukocytapheresis for the treatment of refractory systemic-onset juvenile idiopathic arthritis.

Authors:  Hiroshi Tanaka; Koji Tsugawa; Tohru Nakahata; Koichi Suzuki; Etsuro Ito
Journal:  Clin Rheumatol       Date:  2006-03-25       Impact factor: 2.980

4.  Evaluation of filtration leucocytapheresis for use in the treatment of patients with rheumatoid arthritis.

Authors:  Y Ueki; S Yamasaki; Y Kanamoto; T Kawazu; M Yano; K Matsumoto; S Miyake; Y Tominaga; U Iwamoto; J Suemitsu; Y Matsuno; Y Sizume; Y Takenaka; K Eguchi
Journal:  Rheumatology (Oxford)       Date:  2000-02       Impact factor: 7.580

5.  Massive gastrointestinal haemorrhage in isolated intestinal Henoch-Schonlein purpura with response to intravenous immunoglobulin infusion.

Authors:  Andrew A O Fagbemi; Franco Torrente; Andrew J W Hilson; Michael A Thomson; Robert B Heuschkel; Simon H Murch
Journal:  Eur J Pediatr       Date:  2006-11-21       Impact factor: 3.183

6.  Successful treatment with leukocytapheresis in refractory Henoch-Schönlein purpura: case report.

Authors:  Tohru Nakahata; Hiroshi Tanaka; Koichi Suzuki; Etsuro Ito
Journal:  Clin Rheumatol       Date:  2003-09       Impact factor: 2.980
  6 in total
  1 in total

1.  Risk Factors Associated with Renal Involvement in Childhood Henoch-Schönlein Purpura: A Meta-Analysis.

Authors:  Han Chan; Yan-Ling Tang; Xiao-Hang Lv; Gao-Fu Zhang; Mo Wang; Hai-Ping Yang; Qiu Li
Journal:  PLoS One       Date:  2016-11-30       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.